Tehran University of Medical Sciences

Science Communicator Platform

Share By
A Review on Hematologic Malignant Patients Infected With 2019 Novel Coronavirus Publisher



Lotfali E1 ; Ghasemi R2 ; Mardani M3 ; Fattahi A4 ; Rezaei K2 ; Toreyhi H2 ; Abolghasemi S3
Authors

Source: Archives of Clinical Infectious Diseases Published:2020


Abstract

Since late 2019, when novel coronavirus pneumonia emerged in China and spread worldwide, there has been a need for data con-cerning the clinical characteristics of infected immunocompromised patients. It has been reported that a significant mortality rate occurs in individuals with underlying comorbidities such as hematologic malignancies. Therefore, it is vital to illustrate the clinical manifestations and outcomes of COVID-19 in these vulnerable patients and identify safe therapeutic strategies. This study reviewed the clinical course, laboratory findings, and risk factors associated with hematologic malignant patients with COVID-19 along with the management and therapeutic regimens. © 2020, Author(s).
Related Docs
View other Related Docs
1. Challenges Posed by Covid-19 in Cancer Patients: A Narrative Review, Cancer Medicine (2022)
2. Cancer and Coronavirus Disease (Covid-19): Comorbidity, Mechanical Ventilation, and Death Risk, Journal of Gastrointestinal Cancer (2021)
3. Clinical Characteristics, Laboratory Findings, Radiographic Signs and Outcomes of 61,742 Patients With Confirmed Covid-19 Infection: A Systematic Review and Meta-Analysis, Microbial Pathogenesis (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Mohammad Ali Mansournia (2)
Other Related Docs
4. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
5. Risk and Predictors of In-Hospital Mortality From Covid-19 in Patients With Diabetes and Cardiovascular Disease, Diabetology and Metabolic Syndrome (2020)
6. Covid-19 and Cancer: A Comparative Case Series, Cancer Treatment and Research Communications (2021)
7. Sars-Cov-2 Infection and Severity in Patients With Hematologic Malignancies: A Systematic Review, Infectious Disorders - Drug Targets (2023)
8. Surgical Coronary Revascularization in Patients With Covid-19; Complications and Outcomes: A Retrospective Cohort Study, Health Science Reports (2022)
9. Late Complications of Covid-19; a Systematic Review of Current Evidence, Archives of Academic Emergency Medicine (2020)
10. Association Between Serum Inflammatory Parameters and the Disease Severity in Covid-19 Patients, Journal of Clinical Laboratory Analysis (2022)
11. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
12. Risk Factors Prediction, Clinical Outcomes, and Mortality In Covid-19 Patients, Journal of Medical Virology (2021)
13. Risk Factors of Developing Critical Conditions in Iranian Patients With Covid-19, Global Epidemiology (2021)
14. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
15. Immune-Epidemiological Parameters of the Novel Coronavirus–A Perspective, Expert Review of Clinical Immunology (2020)
16. Neutrophil to Lymphocyte Ratio (Nlr) and Derived Nlr Combination: A Cost-Effective Predictor of Moderate to Severe Covid-19 Progression, Iranian Journal of Allergy# Asthma and Immunology (2022)
17. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
18. Children With Sars-Cov-2 Infection During the Novel Coronaviral Disease (Covid-19) Outbreak in Iran: An Alarming Concern for Severity and Mortality of the Disease, BMC Infectious Diseases (2022)
19. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
20. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in Covid-19: A Multisystem Disease, Advances in Experimental Medicine and Biology (2021)